Binah Capital Group Inc. (BCG) Stock Price

2.41 ▲ +0.15 (+6.64%)
Open: 2.2662 Vol: 4.61K Day's range: 2.2662 - 2.45 Feb 10, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BCG Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.36▲ 2.37▲ 2.37▲ 2.34▲ 2.40▲
MA10 2.43▼ 2.43▼ 2.42▼ 2.35▲ 2.42▼
MA20 2.44▼ 2.41▲ 2.41▼ 2.40▲ 2.21▲
MA50 2.47▼ 2.50▼ 2.52▼ 2.44▼ 2.12▲
MA100 2.56▼ 2.58▼ 2.53▼ 2.13▲ N/A    
MA200 2.62▼ 2.60▼ 2.38▲ 2.11▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.008▼ -0.005▼ -0.004▼ -0.012▼ 0.022▲
RSI 47.582▼ 47.273▼ 47.493▼ 50.357▲ 52.758▲
STOCH 33.083     46.000     46.000     28.289     40.764    
WILL %R -40.000     -40.000     -40.000     -62.791     -50.739    
CCI -36.015     -28.187     -13.357     -33.725     -13.609    
Latest Filters Detected On BCG
BBANDS $BCG Bollinger Bands Contracting Set Alert
RSI $BCG RSI(14) Crossed Above 50 Set Alert
MA $BCG Price Crossed Above MA(13) Set Alert
MA $BCG Price Crossed Above MA(7) Set Alert
Binah Capital Group Inc. News
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026
Tuesday, January 27, 2026 11:18 AM
With $202.3M in cash and an expanded $125M debt facility, ENGN is financially equipped to advance pivotal Cohort 1 and pursue BLA filing. Read more on the stock here.
ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission
Wednesday, January 21, 2026 07:46 AM
Shares of ImmunityBio IBRX surged 17.4% after it announced a recent face-to-face meeting with senior FDA officials to align on the regulatory path forward for Anktiva in an additional indication. IBRX ...
ANKTIVA® with BCG Demonstrates 96% Survival from Bladder Cancer at Three Years with Median Survival Not Yet Reached in BCG-Unresponsive High-Grade Papillary-Only Non-Muscle ...
Tuesday, December 16, 2025 06:00 AM
CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus ...
BCG historical stock data
date open high low close volume
10/02/26 2.2662 2.45 2.2662 2.41 4,610
09/02/26 2.34 2.379 2.26 2.26 8,500
06/02/26 2.455 2.455 2.31 2.35 7,581
05/02/26 2.40 2.41 2.25 2.27 10,346
04/02/26 2.435 2.45 2.35 2.40 6,133
03/02/26 2.42 2.545 2.40 2.42 5,657
02/02/26 2.34 2.47 2.34 2.45 10,060
30/01/26 2.30 2.4329 2.26 2.28 8,640
29/01/26 2.40 2.45 2.303 2.303 10,324
28/01/26 2.43 2.44 2.34 2.38 8,400
Quote Details
52wk Low:1.36
52wk High:5.81
Vol:4.61K
Avg Vol(3m):475.5K
1Y Chng:-16.03%
1M Chng:+7.11%
Add to Watch List
More Information
Index US Composite
Market Cap. 37.52M